Sections
Type

Search results Results 421 to 430 from 3,693


PCCC2017_lung_2_Dr_David_Dawe

Immunotherapy for Lung Cancer David Dawe, MD MSc FRCPC Medical Oncologist, CancerCare Manitoba Assistant Professor, University of Manitoba 2017 Community Cancer Care Educational Conference Presenter Disclosure • Faculty: David ...


PCCC2017_lung_3_Dr_Larry_Tan

Larry Tan, MD – Thoracic Surgery, HSC Community Cancer Care Educational Conference October 27, 2017 • To describe patient referral & triage for the patient with suspected lung cancer • To describe the initial assessment of ...


PCCC2017_lung_4_Dr_Jullian Kim

The Role of Radiotherapy in Modern Lung Cancer Treatment Julian Kim, MD, BEng, MSc, FRCPC Radiation Oncologist Disclosures • None Objectives 1) List 3 potential indications for radiotherapy in the management of lung cancer ...


PCCC2017_lung_5_Dr_Cornelius_Woelk

Palliative Care in Advanced Lung Cancer “Too Much Fluid – Too Little Air” Cornelius Woelk MD,CCFP(PC),FCFP Medical Director of Palliative Care – Southern Health-Sante Sud Medical Director – Boundary Trails Regional Cancer Program hub ...


PCCC2017_lung_6_Dr_Craig_Harlos

Genetic Testing and Targeted Therapies for Incurable Lung Cancer Craig Harlos, MD FRCPC Medical Oncology Community Cancer Care Educational Conference 2017 2017 Community Cancer Care Educational Conference Presenter Disclosure ...


PCCC2017_plenary_1_Allison_Wiens_and_Morgan_Stirling

Practical Health Equity – An Interactive Experience With Morgan & Allison https://giphy.com/ Best played as slideshow 1 Presenters: Morgan Stirling & Allison Wiens Underserved Populations Program & Community Oncology Commercial ...


PCCC2017_plenary_2_Dr_Paul_Daeninck

Medical Cannabis in Cancer Is the Smoke Clearing? Paul Daeninck, MD MSc FRCPC Departments of Internal & Family Medicine University of Manitoba and CancerCare Manitoba Conflict of interest disclosure Faculty: Paul ...


PCCC2017_plenary_3_Medical_Cannabis_-_Q-A

Q: How will this advice change once marijuana is legal for recreation use, and patients can control their own ‘prescribing’? A: I don't think anyone knows the answer to this. ...


PCCC2017_snapper_1_Gisele_Sarbarcher

Febrile Neutropenia What you need to know ! 2017 Community Cancer Care Educational Conference Presenter Disclosure • Faculty: Gisele Sarbacher • Relationships with commercial interests: NONE 2017 Community Cancer Care ...


PCCC2017_snapper_2_Kelly_Bunzeluk

RISKS & BENEFITS OF LUNG CANCER SCREENING Kelly Bunzeluk, Director of Screening, CancerCare Manitoba Disclosures Speaker’s name: Kelly Bunzeluk Relationships with commercial interests: • Grants/Research Support: Roche, ...